The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion

被引:26
作者
Oravec, S
Demuth, K
Myara, I
Hornych, A
机构
[1] Comenius Univ, Dept Internal Med 2, Bratislava, Slovakia
[2] Univ Paris 11, Fac Pharm, Lab Biochim Appl, F-92296 Chatenay Malabry, France
[3] Hop Broussais, Biochim Lab, F-75674 Paris, France
[4] Hop Broussais, INSERM, U430, F-75674 Paris, France
关键词
high density lipoprotein(2); high density lipoprotein(3); human umbilical vein endothelial cells; prostacyclin; thromboxane A(2);
D O I
10.1016/S0049-3848(98)00106-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epidemiological, clinical, and experimental studies have demonstrated that high density lipproteins (HDL) are protective against atherosclerosis, However, the respective influence of two main HDL subfractions (HDL2 and HDL3) on atherosclerosis process is not yet clear. The present study was designed to determine, which HDL subfraction was antiatherogenic in terms of eicosanoid release by human umbilical vein endothelial cells (HUVEC). Endothelial cells were incubated for 4 hours with HDL2 or HDL3 and prostaglandins 6-keto-PGF1 alpha, thromboxane B-2 and prostaglandin E-2 were measured by RIA in culture supernatant, HDL, has a dose dependent stimulatory effect on 6-keto-PGF(1 alpha) release without stimulatory effect on thromboxane B-2 secretion. The 6-keto-PGF(1 alpha)/thromboxane B-2 ratio increased progressively from 1.65 to 4.65 for 0.39 to 6.25 mg HDL protein/ml. The pattern of prostanoid secretion under influence of HDL; showed a predominant response in 6-keto-PGF(1 alpha), and TxB(2) release. As regards PGE(2), both HDL subfractions stimulated considerably secretion of this prostanoid in a dose dependent manner, In terms of PGI(2)/TxA(2) balance the better antiatherogenic effect was observed with HDL, subfraction. (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 33 条
[1]   PROSTAGLANDIN-I2 HALF-LIFE REGULATED BY HIGH-DENSITY-LIPOPROTEIN IS DECREASED IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA-PECTORIS [J].
AOYAMA, T ;
YUI, Y ;
MORISHITA, H ;
KAWAI, C .
CIRCULATION, 1990, 81 (06) :1784-1791
[2]   HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS AS MARKERS OF EARLY ATHEROSCLEROSIS [J].
ATGER, V ;
GIRAL, P ;
SIMON, A ;
CAMBILLAU, M ;
LEVENSON, J ;
GARIEPY, J ;
MEGNIEN, JL ;
MOATTI, N ;
SEGOND, P ;
BADET, D ;
BAYLACLEBOTT, C ;
DEBONNIERES, A ;
BORIE, A ;
BOURILLON, MF ;
BOURSIER, J ;
BRESSLER, S ;
BRU, M ;
CHENET, M ;
CORTEEL, P ;
COULANGE, C ;
DELMOTTEDEVOCELLE, C ;
DEMURE, B ;
DOUGUET, MT ;
DUBOST, M ;
DRUMARE, T ;
ESTEVE, D ;
FRAGNY, M ;
GALAMAND, O ;
GIARD, AM ;
GITEL, R ;
GUILBERT, C ;
HAGE, H ;
KIESGEN, F ;
LAMOTHE, E ;
LANOISELEE, C ;
LEBLANC, ML ;
LECHEVANTON, N ;
LEPRINCE, I ;
MARTY, A ;
MIARA, D ;
MILLET, B ;
OZIEL, J ;
PARINI, A ;
PASTEAU, MC ;
PICARD, M ;
PUPPONI, MM ;
QUINIO, C ;
RAULET, F ;
ROCCA, ML ;
SZABASON, F .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (02) :127-131
[3]  
BONNER G, 1989, PROSTACYCLIN HYPERTE
[4]   DECREASED HDL2 AND HDL3 CHOLESTEROL, APO A-I AND APO A-II, AND INCREASED RISK OF MYOCARDIAL-INFARCTION [J].
BURING, JE ;
OCONNOR, GT ;
GOLDHABER, SZ ;
ROSNER, B ;
HERBERT, PN ;
BLUM, CB ;
BRESLOW, JL ;
HENNEKENS, CH .
CIRCULATION, 1992, 85 (01) :22-29
[5]  
Chernyshov VA, 1995, TERAPEVT ARKH, V67, P64
[6]   RELATION OF THE LEVEL OF HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS TO THE PRESENCE AND EXTENT OF CORONARY-ARTERY DISEASE [J].
DREXEL, H ;
AMANN, FW ;
RENTSCH, K ;
NEUENSCHWANDER, C ;
LUETHY, A ;
KHAN, SI ;
FOLLATH, F .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (04) :436-440
[7]  
FLEISHER LN, 1982, J BIOL CHEM, V257, P6653
[8]   MODERATE ALCOHOL INTAKE, INCREASED LEVELS OF HIGH-DENSITY-LIPOPROTEIN AND ITS SUBFRACTIONS, AND DECREASED RISK OF MYOCARDIAL-INFARCTION [J].
GAZIANO, JM ;
BURING, JE ;
BRESLOW, JL ;
GOLDHABER, SZ ;
ROSNER, B ;
VANDENBURGH, M ;
WILLETT, W ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1829-1834
[9]  
GRAJA D, 1995, HUM HYPERTENS, V9, P753
[10]   MEDIATORS PRODUCED BY THE ENDOTHELIAL-CELL [J].
GRYGLEWSKI, RJ ;
BOTTING, RM ;
VANE, JR .
HYPERTENSION, 1988, 12 (06) :530-548